Cargando…
A novel model for treatment of hypertrophic pachymeningitis
OBJECTIVE: Immunoglobulin (Ig)G4‐related disease is a major cause of hypertrophic pachymeningitis (HP), presenting as a progressive thickening of the dura mater. HP lacks an animal model to determine its underlying mechanisms. We developed a suitable animal model for the treatment of HP. METHODS: We...
Autores principales: | Cui, Yiwen, Masaki, Katsuhisa, Zhang, Xu, Yamasaki, Ryo, Fujii, Takayuki, Ogata, Hidenori, Hayashida, Shotaro, Yamaguchi, Hiroo, Hyodo, Fuminori, Eto, Hinako, Koyama, Sachiko, Iinuma, Kyoko, Yonekawa, Tomomi, Matsushita, Takuya, Yoshida, Mari, Yamada, Kazunori, Kawano, Mitsuhiro, Malissen, Marie, Malissen, Bernard, Kira, Junichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414490/ https://www.ncbi.nlm.nih.gov/pubmed/30911567 http://dx.doi.org/10.1002/acn3.715 |
Ejemplares similares
-
Hypertrophic pachymeningitis
por: Karthik, S. N, et al.
Publicado: (2011) -
Tuberculous Hypertrophic Pachymeningitis
por: Cordeiro, Nikhil L, et al.
Publicado: (2021) -
Hypertrophic Pachymeningitis Accompanying Scleritis
por: Oka, Kosuke, et al.
Publicado: (2017) -
Hypertrophic Pachymeningitis in Sjögren's Syndrome
por: Nakano, Yumiko, et al.
Publicado: (2017) -
Diffuse Hypertrophic Pachymeningeal Tuberculosis
por: Chotmongkol, Verajit, et al.
Publicado: (2020)